Read the latest
MedTech & Biotech News
Glucose Fuel Cell to Power Medical Implants
Scientists at MIT created a glucose fuel cell that is small and powerful enough to...
Read More
Smart Stent Monitors Hemodynamics
Researchers at the Georgia Institute of Technology have developed a smart stent that can monitor...
Read MoreMerck to pay up to $1.4B in cancer deal with Kelun, but details are scarce
Merck to pay up to $1.4B in cancer deal with Kelun, but details are scarce...
Read MoreApplied Molecular Transport’s co-founder exits along with 40% of staff as early pipeline activity paused
Applied Molecular Transport’s co-founder exits along with 40% of staff as early pipeline activity paused...
Read More'We just don’t have the studies': New report details critical diversity shortcomings in US clinical research
'We just don’t have the studies': New report details critical diversity shortcomings in US clinical...
Read MoreFlagship Pioneering unfurls cell and gene therapy company Sonata Therapeutics
Flagship Pioneering unfurls cell and gene therapy company Sonata Therapeutics May 18, 2022 5:39 am...
Read MoreBarber buzzes into Aquestive CEO post as Kendall leaves amid FDA delay
Barber buzzes into Aquestive CEO post as Kendall leaves amid FDA delay May 18, 2022...
Read MoreWith its lead gene therapy nearing the clinic, SwanBio leans heavily on Syncona to close $56M series B
With its lead gene therapy nearing the clinic, SwanBio leans heavily on Syncona to close...
Read MorePfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse events
Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of...
Read MoreFDA has change of heart, plans to convene advisory meeting for Cytokinetics' cardiac med
FDA has change of heart, plans to convene advisory meeting for Cytokinetics' cardiac med May...
Read MoreAmpio's years of troubles come to a head with internal investigation, trio of COVID trial failures
Ampio's years of troubles come to a head with internal investigation, trio of COVID trial...
Read MoreScholar Rock in a hard place as biotech lays off 25% of staff, narrows pipeline and loses CMO
Scholar Rock in a hard place as biotech lays off 25% of staff, narrows pipeline...
Read MoreAiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center
Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center...
Read MoreAstraZeneca bags pan-variant COVID-19 antibodies from stealthy biotech in $157M deal
AstraZeneca bags pan-variant COVID-19 antibodies from stealthy biotech in $157M deal May 17, 2022 2:06...
Read MoreRemix closes $70M funding with pipeline 'really humming,' but to what tune?
Remix closes $70M funding with pipeline 'really humming,' but to what tune? May 16, 2022...
Read MoreAfter 14 years, Agios is looking for a partner to tango with, but tough changes lie ahead
After 14 years, Agios is looking for a partner to tango with, but tough changes...
Read More
Virtual Clinical Trials: Interview with Ivan Jarry, CEO at ObvioHealth
Decentralized and virtual clinical trials are gaining prominence, particularly since the COVID-19 pandemic which made...
Read MoreVC firm Sofinnova banks $1B from Apollo to invest in early-stage biotech solutions
VC firm Sofinnova banks $1B from Apollo to invest in early-stage biotech solutions May 16,...
Read More
Wearable Uses Microneedles to Track Metabolism
A team of researchers at the University of California San Diego created a wearable device...
Read MoreAbbVie coughs up nearly $50M for Cugene's autoimmune med in a bid to shore up life post-Humira
AbbVie coughs up nearly $50M for Cugene's autoimmune med in a bid to shore up...
Read MoreTo TIGIT or not to TIGIT? Roche's latest trial flop casts shadow on Big Pharma's $6B bet
To TIGIT or not to TIGIT? Roche's latest trial flop casts shadow on Big Pharma's...
Read MoreFrom Redditors to creditors: Orphazyme’s wild ride ends with $13M sale to satisfy bankruptcy court
From Redditors to creditors: Orphazyme’s wild ride ends with $13M sale to satisfy bankruptcy court...
Read MoreShionogi splashes $100M on F2G’s rare fungal disease drug to unlock new class of medicine
Shionogi splashes $100M on F2G’s rare fungal disease drug to unlock new class of medicine...
Read MoreKriya cashes in $270M series C to further finance all-in-one gene therapy biz
Kriya cashes in $270M series C to further finance all-in-one gene therapy biz May 15,...
Read More